Sodium Chloride 23.4% Injection Shortage
Last Updated: July 2, 2025
Status: Resolved
Resolved:
- Sodium Chloride 23.4%, Injection, 4 meq/1 mL (Fresenius Kabi USA, LLC)
- Sodium Chloride, Injection, 400 mEq/100 mL (4 mEq/mL) (Hospira, Inc., a Pfizer Company)
Sodium Chloride 23.4%, Injection, 4 meq/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-099-63Status: Resolved
Date of update: July 2, 2025
Update type: Revised
Resolved note: Available
Therapeutic category: Gastroenterology; Endocrinology/Metabolism; Total Parenteral Nutrition; Pediatric
Change date: July 2, 2025
Initial posting date: January 1, 2020
Contact info: 888-386-1300
Sodium Chloride 23.4%, Injection, 4 meq/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-093-30Status: Resolved
Date of update: July 2, 2025
Update type: Revised
Resolved note: Available
Therapeutic category: Gastroenterology; Endocrinology/Metabolism; Total Parenteral Nutrition; Pediatric
Change date: July 2, 2025
Initial posting date: September 18, 2023
Contact info: 888-386-1300
Sodium Chloride, Injection, 400 mEq/100 mL (4 mEq/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-1141-02Status: Resolved
Date of update: July 2, 2025
Update type: Revised
Resolved note: Available
Therapeutic category: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition
Change date: July 2, 2025
Initial posting date: January 1, 2020
Contact info: 844-646-4398
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.